Clinical Trial Update: Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical study comparing gusperimus with conventional treatment for granulomatosis with polyangiitis (Wegener's granulomatosis) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis

Drugs mentioned

• Gusperimus (Gusperimus)

Snippet

Sponsor: Nordic Pharma SAS | Conditions: Wegeners Granulomatosis | Phase 3 | Status: TERMINATED